A single high dose of escitalopram increases mismatch negativity without affecting processing negativity or P300 amplitude in healthy volunteers

Journal of Psychopharmacology

Volumn 24, Issue 8, 2010, Pages 1183-1192

  Wienberg, M ^a   Glenthoj, B Y ^a   Jensen, K S ^a   Oranje, B ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

escitalopram; mismatch negativity; P300 amplitude; processing negativity; serotonin

Indexed keywords

ESCITALOPRAM; PLACEBO;

AMPLITUDE MODULATION; ARTICLE; BEHAVIOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; EVENT RELATED POTENTIAL; HUMAN; HUMAN EXPERIMENT; LOW DRUG DOSE; MALE; MISMATCH NEGATIVITY; NORMAL HUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; SEROTONINERGIC SYSTEM; SINGLE DRUG DOSE;

ACOUSTIC STIMULATION; ADULT; ANXIETY DISORDERS; BLOOD PRESSURE; CITALOPRAM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS; HUMANS; MALE; MENTAL PROCESSES; SCHIZOPHRENIA; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; YOUNG ADULT;

EID: 77955123710     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109102606     Document Type: Article

References (57)

1. Aboraya, A., Tien, A., Stevenson, J., Crosby, K. (1998) Schedules for Clinical Assessment in Neuropsychiatry (SCAN). introduction to WVgs mental health community. W V Med J 94: 326-328.
2. Aghajanian, GK, Marek, GJ (1997) Serotonin induces excitatory post-synaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 36: 589-599.
3. Aghajanian, GK, Marek, GJ (2000) Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res Brain Res Rev 31: 302-312.
4. Ahveninen, J., Jaaskelainen, IP, Pennanen, S., Liesivuori, J., Ilmoniemi, RJ, Kahkonen, S. (2003) Auditory selective attention modulated by tryptophan depletion in humans. Neurosci Lett 340: 181-184.
5. Ahveninen, J., Kahkonen, S., Pennanen, S., Liesivuori, J., Ilmoniemi, RJ, Jaaskelainen, IP (2002) Tryptophan depletion effects on EEG and MEG responses suggest serotonergic modulation of auditory involuntary attention in humans. Neuroimage 16: 1052-1061.
6. Alho, K., Paavilainen, P., Reinikainen, K., Sams, M., Naatanen, R. (1986) Separability of different negative components of the event-related potential associated with auditory stimulus processing. Psychophysiology 23: 613-623.
7. Arroll, B., Macgillivray, S., Ogston, S., Reid, I., Sullivan, F., Williams, B., et al. (2005) Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann Fam Med 3: 449-456.
8. Baribeau-Braun, J., Picton, TW, Gosselin, JY (1983) Schizophrenia: A Neurophysiological Evaluation of Abnormal Information Processing. Science 219: 874-876.
9. Braff, DL, Light, GA (2004) Preattentional and attentional cognitive deficits as targets for treating schizophrenia. Psychopharmacology (Berl) 174: 75-85.
10. dgArdhuy, XL, Boeijinga, PH, Renault, B., Luthringer, R., Rinaudo, G., Soufflet, L., et al. (1999) Effects of serotonin-selective and classical antidepressants on the auditory P300 cognitive potential. Neuropsychobiology 40: 207-213.
11. Ford, JM (1999) Schizophrenia: the broken P300 and beyond. Psychophysiology 36: 667-682.
12. Frodl-Bauch, T., Bottlender, R., Hegerl, U. (1999) Neurochemical substrates and neuroanatomical generators of the event-related P300. Neuropsychobiology 40: 86-94.
13. Gene Cos, N., Ring, HA, Pottinger, RC, Barrett, G. (1999) Possible roles for mismatch negativity in neuropsychiatry. Neuropsychiatry Neuropsychol Behav Neurol 12: 17-27.
14. Gutierrez, MM, Abramowitz, W. (2000) Pharmacokinetic comparison of oral solution and tablet formulations of citalopram: a single-dose, randomized, crossover study. Clin Ther 22: 1525-1532.
15. Hansenne, M., Ansseau, M. (1999) P300 event-related potential and serotonin-1A activity in depression. Eur Psychiatry 14: 143-147.
16. Hansenne, M., Pitchot, W., Papart, P., Ansseau, M. (1998) Serotonergic modulation of the P300 event related brain potential. Hum Psychopharmacol Clin Exp 13: 239-243.
17. Ille, N., Berg, P., Scherg, M. (2002) Artifact correction of the ongoing EEG using spatial filters based on artifact and brain signal topographies. J Clin Neurophysiol 19: 113-124.
18. Iwanami, A., Isono, H., Okajima, Y., Noda, Y., Kamijima, K. (1998) Event-related potentials during a selective attention task with short interstimulus intervals in patients with schizophrenia. J Psychiatry Neurosci 23: 45-50.
19. Iwanami, A., Okajima, Y., Isono, H., Shinoda, J., Kasai, K., Hata, A., et al. (2001) Effects of risperidone on event-related potentials in schizophrenic patients. Pharmacopsychiatry 34: 73-79.
20. Javitt, DC, Steinschneider, M., Schroeder, CE, Arezzo, JC (1996) Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc Natl Acad Sci U S A 93: 11962-11967.
21. Jeon, YW, Polich, J. (2003) Meta-analysis of P300 and schizophrenia: patients, paradigms, and practical implications. Psychophysiology 40: 684-701.
22. Kahkonen, S., Makinen, V., Jaaskelainen, IP, Pennanen, S., Liesivuori, J., Ahveninen, J. (2005) Serotonergic modulation of mismatch negativity. Psychiatry Res 138: 61-74.
23. Karaaslan, F., Gonul, AS, Oguz, A., Erdinc, E., Esel, E. (2003) P300 changes in major depressive disorders with and without psychotic features. J Affect Disord 73: 283-287.
24. Lieberman, JA, Mailman, RB, Duncan, G., Sikich, L., Chakos, M., Nichols, DE, et al. (1998) Serotonergic basis of antipsychotic drug effects in schizophrenia. Biol Psychiatry 44: 1099-1117.
25. Liotti, M., Mayberg, HS (2001) The role of functional neuroimaging in the neuropsychology of depression. J Clin Exp Neuropsychol 23: 121-136.
26. Meador, KJ, Loring, DW, Davis, HC, Sethi, KD, Patel, BR, Adams, RJ, et al. (1989) Cholinergic and serotonergic effects on the P3 potential and recent memory. J Clin Exp Neuropsychol 11: 252-260.
27. Meltzer, HY, Li, Z., Kaneda, Y., Ichikawa, J. (2003) Serotonin receptors: their key role in drugs to treat schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27: 1159-1172.
28. Metting van Rijn, AC, Kuiper, AP, Dankers, TE, Grimbergen, CA (1996) Low-cost active electrode improves the resolution in biopotential recordings. Proc of the 18th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Amsterdam, The Netherlands, Track 123-3.
29. Michie, PT, Fox, AM, Ward, PB, Catts, SV, Mcconaghy, N. (1990) Event-related potential indices of selective attention and cortical lateralization in schizophrenia. Psychophysiology 27: 209-227.
30. Mirsky, AF, Anthony, BJ, Duncan, CC, Ahearn, MB, Kellam, SG (1991) Analysis of the elements of attention: a neuropsychological approach. Neuropsychol Rev 2: 109-145.
31. Molina, V., Munoz, F., Martin-Loeches, M., Casado, P., Hinojosa, JA, Iglesias, A. (2004) Long-term olanzapine treatment and p300 parameters in schizophrenia. Neuropsychobiology 50: 182-188.
32. Naatanen, R. (1995) The mismatch negativity: a powerful tool for cognitive neuroscience. Ear Hear 16: 6-18.
33. Naatanen, R., Jacobsen, T., Winkler, I. (2005) Memory-based or afferent processes in mismatch negativity (MMN). a review of the evidence. Psychophysiology 42: 25-32.
34. Naatanen, R., Michie, PT (1979) Early selective-attention effects on the evoked potential: a critical review and reinterpretation. Biol Psychol 8: 81-136.
35. Naatanen, R., Paavilainen, P., Reinikainen, K. (1989) Do event-related potentials to infrequent decrements in duration of auditory stimuli demonstrate a memory trace in man ? Neurosci Lett 107: 347-352.
36. Oranje, B., Jensen, K., Wienberg, M., Glenthoj, BY (2008) Divergent effects of increased serotonergic activity on psychophysiological parameters of human attention. Int J Neuropsychopharmacol 11: 453-463.
37. Oranje, B., van Berckel, BNM, Kemner, C., van Ree, JM, Kahn, RS, Verbaten, MN (2000) The effects of a sub-anaesthetic dose of ketamine on human selective attention. Neuropsychopharmacology 22: 293-302.
38. Polich, J., Ladish, C., Bloom, FE (1990) P300 assessment of early Alzheimergs disease. Electroencephalogr Clin Neurophysiol 77: 179-189.
39. Pritchard, WS, Raz, N., August, GJ (1987) No effect of chronic fenfluramine on the P300 component of the event-related potential. Int J Neurosci 35: 105-110.
40. Raskin, LA, Shaywitz, SE, Shaywitz, BA, Anderson, GM, Cohen, DJ (1984) Neurochemical correlates of attention deficit disorder. Pediatr Clin North Am 31: 387-396.
41. Raskin, SA, Borod, JC, Tweedy, J. (1990) Neuropsychological aspects of Parkinsongs disease. Neuropsychol Rev 1: 185-221.
42. Roth, WT, Pfefferbaum, A., Kelly, AF, Berger, PA, Kopell, BS (1981) Auditory event-related potentials in schizophrenia and depression. Psychiatry Res 4: 199-212.
43. Sahakian, BJ, Owen, AM (1992) Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J. R.Soc.Med. 85 (7). 399-402.
44. Sanz, M., Molina, V., Martin-Loeches, M., Calcedo, A., Rubia, FJ (2001) Auditory P300 event related potential and serotonin reuptake inhibitor treatment in obsessive-compulsive disorder patients. Psychiatry Res 101: 75-81.
45. Semlitsch, HV, Anderer, P., Saletu, B., Binder, GA, Decker, KA (1993) Acute effects of the novel antidepressant venlafaxine on cognitive event-related potentials (P300). eye blink rate and mood in young healthy subjects. Int Clin Psychopharmacol 8: 155-166.
46. Sumich, AL, Kumari, V., Heasman, BC, Gordon, E., Brammer, M. (2006) Abnormal asymmetry of N200 and P300 event-related potentials in subclinical depression. J Affect Disord 92: 171-183.
47. Sutton, S., Braren, M., Zubin, J., John, ER (1965) Evoked-potential correlates of stimulus uncertainty. Science 150: 1187-1188.
48. Todd, J., Michie, PT, Jablensky, AV (2003) Association between reduced duration mismatch negativity (MMN) and raised temporal discrimination thresholds in schizophrenia. Clin Neurophysiol 114: 2061-2070.
49. Umbricht, D., Javitt, D., Novak, G., Bates, J., Pollack, S., Lieberman, J., et al. (1998) Effects of clozapine on auditory event-related potentials in schizophrenia. Biol Psychiatry 44: 716-725.
50. Umbricht, D., Javitt, D., Novak, G., Bates, J., Pollack, S., Lieberman, J., et al. (1999) Effects of risperidone on auditory event-related potentials in schizophrenia. Int J Neuropsychopharmcol 2: 299-304.
51. Umbricht, D., Koller, R., Schmid, L., Skrabo, A., Grubel, C., Huber, T., et al. (2003 a) How specific are deficits in mismatch negativity generation to schizophrenia ? Biol Psychiatry 53: 1120-1131.
52. Umbricht, D., Vollenweider, FX, Schmid, L., Grubel, C., Skrabo, A., Huber, T., et al. (2003 b) Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia. Neuropsychopharmacology 28: 170-181.
53. Umbricht, D., Krljes, S. (2005) Mismatch negativity in schizophrenia: a meta-analysis. Schizophr Res 76: 1-23.
54. Umbricht, D., Schmid, L., Koller, R., Vollenweider, FX, Hell, D., Javitt, DC (2000) Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch Gen Psychiatry 57: 1139-1147.
55. Unrug, A., van Luijtelaar, EL, Coles, MG, Coenen, AM (1997) Event-related potentials in a passive and active auditory condition: effects of diazepam and buspirone on slow wave positivity. Biol Psychol 46: 101-111.
56. Vollenweider, FX, Vontobel, P., Hell, D., Leenders, KL (1999) 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man-a PET study with [11C]raclopride. Neuropsychopharmacology 20: 424-433.
57. Ward, PB, Catts, SV, Fox, AM, Michie, PT, Mcconaghy, N. (1991) Auditory selective attention and event-related potentials in schizophrenia. Br J Psychiatry 158: 534-539.